Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Complement Therapeutics Secures €72 Million in Series A Financing to Advance Novel Therapies Targeting Complement-Mediated Diseases
Complement Therapeutics, a preclinical stage biotechnology company developing novel therapeutics for complement mediated diseases, has […]
Roche’s Tecentriq Plus Avastin Reduced Risk of Cancer Returning in People with Certain Types of Adjuvant Liver Cancer in a Phase III Study
Roche has announced new data from the Phase III IMbrave050 study that show Tecentriq (atezolizumab) […]
Epic Sciences Raises $24M in Series G Financing to Continue Funding Commercialization of DefineMBC
Epic Sciences, a privately held diagnostics company, has completed a $24 million Series G which […]
Merck & XtalPi Collaboration Optimizes Drug Formulations with AI-Powered Techniques
Science and technology company Merck and XtalPi, a pioneering pharmaceutical technology company powered by artificial […]
M2GEN Rebrands to Aster Insights
M2GEN, an oncology bioinformatics company with the most advanced lifetime-consented clinicogenomic data to accelerate medical […]
Oxford Biotech Secures £13.2m to Develop World’s First Treatment for Rare, Incurable and Deadly Disease
SynaptixBio, whose aim is to develop a treatment for the rare genetic central nervous system […]
TORL BioTherapeutics Launches with $158 Million Series B Financing to Advance Development of Novel Oncology Biologics
TORL BioTherapeutics, a biopharmaceutical company focused on developing new biologics for cancer treatment, has announced […]
Function Oncology Launches to Transform the Future of Targeted Cancer Treatment with CRISPR
Function Oncology, a precision medicine company advancing a CRISPR-powered personalized functional genomics platform to transform […]
Amylyx Pharmaceuticals Announces First Participant Dosed in Phase 2 Study of AMX0035 for the Treatment of Wolfram Syndrome
Amylyx Pharmaceuticals has announced that the first participant has been dosed in the HELIOS study, […]
YDS Pharmatech Appoints Dr. Robert Sullivan as Head of Medicinal Chemistry
YDS Pharmatech, a computational drug discovery company specializing in induced proximity, today announced the appointment […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more